The short answer
Dysport is a botulinum toxin type A injectable used at our Greenwich location to soften frown lines and other expression lines. Onset is typically two to five days, often slightly quicker than the alternatives. Dosing units are not interchangeable between neuromodulator brands.
A short message is enough to get started. The team will reply with times and answer any questions first.
Not sure what to ask for? Call 212-535-5905 and talk it through, or speak to the team.
In a market where most patients have a treatment history, a request for Dysport by name usually reflects genuine experience of the difference rather than something read online. Going through that history properly makes the new plan more accurate.
Its onset is typically two to five days. In a market that schedules tightly around travel and events, that is a practical rather than a theoretical advantage.
This is the dysport page. The wider treatment menu for this office sits on the Greenwich clinic page.
Dysport is a botulinum toxin type A preparation used mainly for the frown lines between the eyebrows. Its onset is marginally quicker than the alternatives and its dosing scale is its own.
For the detailed clinical background, including who it does not suit, see the practice-wide dysport page.
| Point of difference | Dysport | Botox | Xeomin |
|---|---|---|---|
| Active ingredient | AbobotulinumtoxinA | OnabotulinumtoxinA | IncobotulinumtoxinA |
| Typical onset | 2 to 5 days | 3 to 7 days | 3 to 7 days |
| Dosing units | Not interchangeable with other brands | Not interchangeable with other brands | Not interchangeable with other brands |
| Often chosen for | Broader areas such as the forehead | Well-established, predictable dosing | A purified, protein-free formulation |
| Duration | Temporary – months, then reassessed | Temporary – months, then reassessed | Temporary – months, then reassessed |
| At the Greenwich office | Decided at your assessment, not from this table | Decided at your assessment, not from this table | Decided at your assessment, not from this table |
The Greenwich Dysport list is experienced and specific. Patients tend to know which areas they want treated and how they want the result to sit, and they expect the clinician to push back where a request would not produce a good outcome.
Forehead treatment features more heavily here than in the neuromodulator lists elsewhere, which is consistent with the product’s diffusion characteristics over a broader area.
Alongside this treatment, patients regularly ask about Botox at our Greenwich office and Juvederm at our Greenwich office. Suitability for combining them is assessed individually.
For the same treatment in a different market, see the dysport page for Highlands.
| Coming from | Approximate drive | Main route |
|---|---|---|
| Cos Cob | 7 minutes | US-1 / East Putnam Avenue |
| Riverside | 8 minutes | US-1 East |
| Old Greenwich | 10 minutes | US-1 East |
| Port Chester, NY | 10 minutes | US-1 West |
| Stamford | 15 minutes | I-95 North |
Travel detail from eight nearby towns is covered under routes into the Greenwich office.
Rather than publish a number that would be wrong for most people, the practice quotes at consultation. Treatment type, area, product volume and session count all move it, and all four are established when you are assessed.
Consultations run with Anita Dormer, MD from start to finish. Aesthetic outcomes turn on judgement about anatomy, which is why a physician makes the call here.
Background on the practice is on the practice background page.
It is the same class of product – botulinum toxin type A – with a slightly quicker typical onset and different diffusion characteristics. The comparison table above sets out the differences.
No. The unit scales are different and are not interchangeable. Dose is planned from a fresh assessment.
Allow at least two weeks so the result has settled and there is room for a review appointment if anything needs adjusting.
It is temporary and wears off over a period of months. Retreatment timing is agreed at review.
Where this page describes how a treatment works, it follows the published sources listed here. They are general and not patient-specific.
Come in for an assessment and talk it through properly. Suitability is decided clinically, and individual results vary between patients.
